شماره ركورد كنفرانس :
3776
عنوان مقاله :
Dual anticancer drug delivery by smart antibacterial nanocomposite based-Tetrazol
پديدآورندگان :
Zakerzadeh Elham Elhamzakerzadeh@gmail.com Azarbaijan Shahid Madani University , Mahkam Mehrdad Azarbaijan Shahid Madani University , Salehi Roya Tabriz University of Medical Sciences, Tabriz
تعداد صفحه :
1
كليدواژه :
,
سال انتشار :
1395
عنوان كنفرانس :
بيست چهارمين سمينار شيمي آلي ايران
زبان مدرك :
انگليسي
چكيده فارسي :
Tetrazole is a cyclic and aromatic compound including a carbon and four nitrogen atoms in a five-membered ring. In the category of heterocyclic compounds, tetrazole derivatives, in particular 5-substituted tetrazoles, are successfully utilized in medicine, biochemistry, agriculture and fine organic synthesis. Also a large number of medicinally important tetrazole heterocyclic incorporated drugs such as antihypertensive, antihistamine, diuretics, antiparasitic, anticancer drugs, inhibitors of thrombosis, and drugs with anti-inflammatory, anesthetic, antifungal, tuberculostatic and antiviral activity approved by the FDA [1].Smart carriers can increase the penetrance and survival of drugs in tumors and decrease the side effect and toxicity related with most anti-cancer drugs. Introducing different stimulusresponsive properties to DDSs is an efficient way to achieve these goals [2].Cancer cells can develop resistance to chemotherapy drugs, but are less likely to develop resistance when multiple drugs are delivered simultaneously. However, different drugs target different parts of the cancer cell [3].In this research a novel antibacterial polymeric nano-system was developed for combination cancer therapy. The synthesized nanocarrier was fully characterized and its antibacterial activity was assessed by MIC values against some bacterias and funguses.DOX and MTX as anticancer drugs were conjugated concurrently to nanocarrier with an encapsulation efficiency of about 95% and sustained the release of both drugs up to 20 days with apparent pH-triggered controlled release manner. Cell viability tests affirmed that the coadministration of DOX with MTX lead to an efficient anticancer performance to MCF7 cell lines verified by MTT assay test.
كشور :
ايران
لينک به اين مدرک :
بازگشت